Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -96.67% |
Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
Mar. 21 | North American Morning Briefing : Investors -2- | DJ |
Business Summary
Number of employees: 125
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 18 | 100.0 % | 50 | 100.0 % | +184.10% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 18 | 100.0 % | 50 | 100.0 % | +184.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sergio Alegre
CMP | Compliance Officer | - | 16-07-31 |
James Schaub
COO | Chief Operating Officer | 42 | 15-12-31 |
Michael Depetris
AUD | Comptroller/Controller/Auditor | - | 22-04-17 |
Jarret Miller
HRO | Human Resources Officer | - | 15-12-31 |
General Counsel | 60 | 13-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Cowan
BRD | Director/Board Member | 70 | 18-12-31 |
Alisa Lask
BRD | Director/Board Member | 53 | 22-08-09 |
Michael DeBiasi
BRD | Director/Board Member | 48 | 19-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 111,406,043 | 107,306,425 ( 96.32 %) | 0 | 96.32 % |
Company contact information
RVL Pharmaceuticals Plc
400 Crossing Boulevard
08807, Bridgewater
+908 809 1300
http://www.rvlpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-96.67% | 11.14K | |
-1.85% | 89.87B | |
-1.05% | 37.57B | |
-11.74% | 32.75B | |
+61.85% | 26.47B | |
-20.89% | 14.25B | |
-6.40% | 12.99B | |
-11.42% | 11.93B | |
-47.67% | 10.84B | |
+5.99% | 9.11B |
- Stock Market
- Equities
- RVLPQ Stock
- Company RVL Pharmaceuticals plc